Weili Yu

482 total citations
37 papers, 381 citations indexed

About

Weili Yu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Weili Yu has authored 37 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Weili Yu's work include SARS-CoV-2 and COVID-19 Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Hemoglobin structure and function (6 papers). Weili Yu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Hemoglobin structure and function (6 papers). Weili Yu collaborates with scholars based in China and United States. Weili Yu's co-authors include Tao Hu, Lijuan Shen, Qingrui Huang, Yunxia He, Shaoyang Ji, Juankun Zhang, Xue Wan, Chunyang Hu, Hong Zhou and Lian Zhao and has published in prestigious journals such as ACS Applied Materials & Interfaces, European Journal of Pharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Weili Yu

37 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weili Yu China 11 153 104 76 55 40 37 381
Wei Zhong China 16 326 2.1× 41 0.4× 47 0.6× 42 0.8× 46 1.1× 34 532
Vincent V. Suzara United States 6 195 1.3× 112 1.1× 73 1.0× 206 3.7× 51 1.3× 8 561
Daniel H. Stones United Kingdom 10 172 1.1× 70 0.7× 85 1.1× 35 0.6× 24 0.6× 16 433
Michaela Marshall United States 9 87 0.6× 79 0.8× 81 1.1× 52 0.9× 17 0.4× 17 275
Yu-Tsueng Liu United States 9 216 1.4× 43 0.4× 88 1.2× 72 1.3× 32 0.8× 9 485
Tingting Jia China 14 259 1.7× 74 0.7× 66 0.9× 81 1.5× 35 0.9× 37 545
Shuihong Cheng China 13 301 2.0× 59 0.6× 32 0.4× 83 1.5× 50 1.3× 27 535
Isabelle Ricard France 15 187 1.2× 71 0.7× 65 0.9× 92 1.7× 10 0.3× 19 515
Rob van Dalen Netherlands 9 244 1.6× 122 1.2× 205 2.7× 74 1.3× 22 0.6× 17 535

Countries citing papers authored by Weili Yu

Since Specialization
Citations

This map shows the geographic impact of Weili Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Yu more than expected).

Fields of papers citing papers by Weili Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Yu. The network helps show where Weili Yu may publish in the future.

Co-authorship network of co-authors of Weili Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Yu. A scholar is included among the top collaborators of Weili Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Yu. Weili Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Weili, Ravi Shanker, Pratik Doshi, et al.. (2025). The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic. Communications Medicine. 5(1). 80–80. 4 indexed citations
2.
Shen, Lijuan, et al.. (2024). A Haloalkane Dehalogenase DhaA Nanoparticle Based on Pullulan Conjugation and Polyethyleneimine Adsorption. Applied Biochemistry and Biotechnology. 197(3). 1662–1677. 1 indexed citations
3.
Zhao, Fengbo, Weili Yu, Yi Xia, et al.. (2024). Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma. European Journal of Pharmacology. 974. 176601–176601. 7 indexed citations
4.
Yan, Wenying, Weili Yu, Lijuan Shen, et al.. (2023). Hydroxyethyl Starch–Bovine Hemoglobin Conjugate as an Effective Oxygen Carrier with the Ability to Expand Plasma. ACS Omega. 8(12). 11447–11456. 3 indexed citations
5.
Yu, Weili, et al.. (2023). Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration. ACS Applied Materials & Interfaces. 15(30). 35895–35905. 10 indexed citations
6.
Yan, Wenying, et al.. (2023). A SARS-CoV-2 nanoparticle vaccine based on chemical conjugation of loxoribine and SpyCatcher/SpyTag. International Journal of Biological Macromolecules. 253(Pt 5). 127159–127159. 5 indexed citations
7.
Yu, Weili, et al.. (2022). Conjugation with loxoribine and mannan improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein. European Journal of Pharmaceutics and Biopharmaceutics. 172. 193–202. 5 indexed citations
8.
He, Yunxia, et al.. (2022). A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan. International Journal of Biological Macromolecules. 222(Pt A). 661–670. 5 indexed citations
11.
Yu, Weili, et al.. (2021). Conjugation of haloalkane dehalogenase DhaA with arabinogalactan to increase its stability. Journal of Biotechnology. 335. 47–54. 4 indexed citations
12.
Shan, Yue, Weili Yu, Lijuan Shen, et al.. (2021). Conjugation with inulin improves the environmental stability of haloalkane dehalogenase DhaA. Enzyme and Microbial Technology. 149. 109832–109832. 7 indexed citations
13.
Yan, Wenying, Lijuan Shen, Weili Yu, et al.. (2020). A triply modified human adult hemoglobin with low oxygen affinity, rapid autoxidation and high tetramer stability. International Journal of Biological Macromolecules. 159. 236–242. 4 indexed citations
14.
Hu, Chunyang, et al.. (2018). Conjugation with Eight-Arm PEG Markedly Improves the In Vitro Activity and Prolongs the Blood Circulation of Staphylokinase. Bioconjugate Chemistry. 29(2). 451–458. 19 indexed citations
15.
Zhang, Jun, Ying Wang, Shan Zhang, et al.. (2018). In vitro and in vivo investigation of the novel Dex-bHb as oxygen carriers. Artificial Cells Nanomedicine and Biotechnology. 46(sup3). 133–137. 3 indexed citations
16.
Wei, Dong, et al.. (2018). The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine. Biotechnology Letters. 40(8). 1263–1270. 1 indexed citations
17.
Zheng, He, et al.. (2018). An effective immobilized haloalkane dehalogenase DhaA from Rhodococcus rhodochrous by adsorption, crosslink and PEGylation on meso-cellular foam. International Journal of Biological Macromolecules. 125. 1016–1023. 11 indexed citations
18.
Sun, Xiaowei, et al.. (2017). Conjugation Reaction with 8-Arm PEG Markedly Improves the Immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 Fusion Protein. Bioconjugate Chemistry. 28(6). 1658–1668. 8 indexed citations
19.
Chang, Xin, et al.. (2017). Conjugation of PEG-hexadecane markedly increases the immunogenicity of pneumococcal polysaccharide conjugate vaccine. Vaccine. 35(13). 1698–1704. 7 indexed citations
20.
Yu, Weili, et al.. (2017). PEGylation with the thiosuccinimido butylamine linker significantly increases the stability of haloalkane dehalogenase DhaA. Journal of Biotechnology. 254. 25–33. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026